In glioma, chaetocin was previously shown to induce ROS-mediated apoptosis through the Atm–Yap1 axis and Jnk-dependent metabolic adaptation, where chaetocin reduced lactate levels, ATP production and glucose uptake51. The gene discussed is YAP1; the disease is glioma.